New Drug Delivery Device May Treat Retinal Damage Caused by Diabetes
July 5, 2011
The University of British Columbia recently announced that a team of its engineers has developed a drug delivery device no larger than the head of a pin that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes.
The drug delivery system is triggered by an external magnetic field. The team accomplished this by sealing the reservoir of the implantable device with an elastic magnetic polydimethylsiloxane (silicone) membrane. A magnetic field causes the membrane to deform and discharge a specific amount of the drug, much like squeezing water out of a flexible bottle.
Click here to read the full release.
You might also enjoy...
- Can External Drug Delivery System Improve Treatment of Retinal Disease?
- Intravitreal Drug Delivery System Okay for Diabetic Macular Edema
- iVeena Implant May One Day Spare Macular Degeneration Patients the Pain of Eye Injections
- QLT Announces Phase II Clinical Trial Results for the Olopatadine Punctal Plug Delivery System
- Can Microbots Deliver Drugs into the Eye to Treat Macular Degeneration?
Comments
Jump down to form below to submit your own comments
UCLA researchers demonstrated that an over-the-counter dietary supplement may help inhibit development of insulin resistance and glucose intolerance, conditions that are involved in the development of Type 2 diabetes and metabolic syndrome, which affect millions worldwide.